- Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethy…
Number of the records: 1  

Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection

  1. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection / Z. J. Liu ... [et al.]. -- ilustr., grafy, tab. -- Bibliogr. odkazy.
    In: Neoplasma. -- ISSN 0028-2685. -- Vol. 64, no. 5 (2017), s. 795-802.
    karcinóm hepatocelulárny - chirurgia - genetika - krv * gény supresorové nádorové * metylácia DNA * oblasti promótorové, v genetike * recidíva nádoru, lokálna * biomarkery nádorové * analýza prežívania * prognóza * LINE-1 hypometylácia * RASSF1A hypermetylácia
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.